FoodMay 31, 2023
TruVision Health reFORM recall — FDA F-0942-2023
The products contain DMHA and/or hordenine which FDA has determined are not acceptable dietary ingredients.
Class IIFDA: OngoingTruVision Health LLC
Latest records
Latest recalls — page 563
The newest recall records with useful source details are listed here.
FoodMay 31, 2023
TruVision Health TruWeight and Energy Gen 2+ 60 Count recall — FDA F-0944-2023
The products contain DMHA and/or hordenine which FDA has determined are not acceptable dietary ingredients.
Class IIFDA: OngoingTruVision Health LLC
FoodMay 31, 2023
GH Foods The Traveler's Best Ham & Swiss on Pretzel Roll Smoked Ham and recall — FDA F-0895-2023
Undeclared allergen; sesame seeds
Class IIFDA: TerminatedGH Foods LLC
FoodMay 31, 2023
TruVision Health truControl W/Dynamine 60 ct recall — FDA F-0943-2023
The products contain DMHA and/or hordenine which FDA has determined are not acceptable dietary ingredients.
Class IIFDA: OngoingTruVision Health LLC
FoodMay 31, 2023
Brooklyn Delhi 5 oz., glass bottle recall — FDA F-0918-2023
Product may be become pressurized from fermentation and pose a safety risk to consumers who may sustain injuries to their eyes, face, and hands when opening the bottles.
Class IIFDA: TerminatedBrooklyn Delhi
FoodMay 31, 2023
Hms Host International Ultra Tuna Salad Sandwich, brand DishD'Lish recall — FDA F-0932-2023
Ultra Tuna Salad Sandwich label declares Mayo and Bread, but label does NOT declare Egg and Wheat.
Class IFDA: TerminatedHms Host International Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services PHENYLephrine added to 0.9% sodium chloride, 20 mg/250 recall — FDA D-0733-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services dilTIAZem added to 0.9% sodium chloride, 125 mg/125 mL* recall — FDA D-0713-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Modified del Nido Microplegia recall — FDA D-0681-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services heparin added to 0.9% sodium chloride, 7,500 units/1,000 recall — FDA D-0726-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services oxyTOCIN 60 units added to 0.9% sodium chloride 1,000 mL recall — FDA D-0711-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, LEESBURG CARDIOPLEGIA recall — FDA D-0680-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Neonatal PN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0698-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, del Nido Formula recall — FDA D-0668-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Modified St Thomas Solution, low recall — FDA D-0669-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL recall — FDA D-0708-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services tromethamine 0.3 Molar, 50 mL syringe recall — FDA D-0741-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Induction 4:1 Plasmalyte, HIGH recall — FDA D-0676-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services heparin added to 0.9% sodium chloride, 5,000 units/500 recall — FDA D-0732-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Maintenance 8:1 non-enriched, low recall — FDA D-0679-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services vancomycin added to 0.9% sodium chloride, 1.5 g/500 mL* recall — FDA D-0725-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Potassium Acetate Injection, 2 mEq/mL, 500 ml bag recall — FDA D-0752-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services PHENYLephrine added to 0.9% sodium chloride, 25 mg/250 recall — FDA D-0727-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Reperfusate 4:1 low potassium recall — FDA D-0652-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
October 2026110 records · 3 categoriesSeptember 2026364 records · 4 categoriesAugust 2026302 records · 4 categoriesJuly 2026370 records · 4 categoriesJune 2026376 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categories